Bilateral Femoral Insufficiency Fractures Likely Related to Long-Term Alendronate Therapy

Osteoporosis-related fractures are a major public health problem and one in two women and one in four men are affected with osteoporosis-related fractures. Alendronate (Fosamax) is one of the first bisphosphonates used to treat osteoporosis effectively. Recently, however, there is a concern regardin...

Full description

Saved in:
Bibliographic Details
Main Authors: Ravindra Gudena, Jason Werle, Kelly Johnston
Format: Article
Language:English
Published: Wiley 2011-01-01
Series:Journal of Osteoporosis
Online Access:http://dx.doi.org/10.4061/2011/810697
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832567539767443456
author Ravindra Gudena
Jason Werle
Kelly Johnston
author_facet Ravindra Gudena
Jason Werle
Kelly Johnston
author_sort Ravindra Gudena
collection DOAJ
description Osteoporosis-related fractures are a major public health problem and one in two women and one in four men are affected with osteoporosis-related fractures. Alendronate (Fosamax) is one of the first bisphosphonates used to treat osteoporosis effectively. Recently, however, there is a concern regarding long bone insufficiency fractures related to long-term alendronate therapy. We report a case of bilateral femoral insufficiency fractures likely related to long-term alendronate therapy, the classic symptoms, signs, and treatment of these fractures.
format Article
id doaj-art-aa52ee5fa6664db698504519f86dc2f6
institution Kabale University
issn 2042-0064
language English
publishDate 2011-01-01
publisher Wiley
record_format Article
series Journal of Osteoporosis
spelling doaj-art-aa52ee5fa6664db698504519f86dc2f62025-02-03T01:01:19ZengWileyJournal of Osteoporosis2042-00642011-01-01201110.4061/2011/810697810697Bilateral Femoral Insufficiency Fractures Likely Related to Long-Term Alendronate TherapyRavindra Gudena0Jason Werle1Kelly Johnston2Department of Orthopedics, University of Calgary, 711B, 3607-49 ST NW, Calgary, Alberta, T3A 2H3, CanadaDepartment of Orthopedics, University of Calgary, 711B, 3607-49 ST NW, Calgary, Alberta, T3A 2H3, CanadaDepartment of Orthopedics, University of Calgary, 711B, 3607-49 ST NW, Calgary, Alberta, T3A 2H3, CanadaOsteoporosis-related fractures are a major public health problem and one in two women and one in four men are affected with osteoporosis-related fractures. Alendronate (Fosamax) is one of the first bisphosphonates used to treat osteoporosis effectively. Recently, however, there is a concern regarding long bone insufficiency fractures related to long-term alendronate therapy. We report a case of bilateral femoral insufficiency fractures likely related to long-term alendronate therapy, the classic symptoms, signs, and treatment of these fractures.http://dx.doi.org/10.4061/2011/810697
spellingShingle Ravindra Gudena
Jason Werle
Kelly Johnston
Bilateral Femoral Insufficiency Fractures Likely Related to Long-Term Alendronate Therapy
Journal of Osteoporosis
title Bilateral Femoral Insufficiency Fractures Likely Related to Long-Term Alendronate Therapy
title_full Bilateral Femoral Insufficiency Fractures Likely Related to Long-Term Alendronate Therapy
title_fullStr Bilateral Femoral Insufficiency Fractures Likely Related to Long-Term Alendronate Therapy
title_full_unstemmed Bilateral Femoral Insufficiency Fractures Likely Related to Long-Term Alendronate Therapy
title_short Bilateral Femoral Insufficiency Fractures Likely Related to Long-Term Alendronate Therapy
title_sort bilateral femoral insufficiency fractures likely related to long term alendronate therapy
url http://dx.doi.org/10.4061/2011/810697
work_keys_str_mv AT ravindragudena bilateralfemoralinsufficiencyfractureslikelyrelatedtolongtermalendronatetherapy
AT jasonwerle bilateralfemoralinsufficiencyfractureslikelyrelatedtolongtermalendronatetherapy
AT kellyjohnston bilateralfemoralinsufficiencyfractureslikelyrelatedtolongtermalendronatetherapy